RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Juan Noveron to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Juan Noveron has written about Dose-Response Relationship, Drug.
Juan Noveron
Connection Strength
0.192
Dose-Response Relationship, Drug
  1. Rasafar N, Sanchez-Michael LA, Torres A, Andujo LA, Gutierrez DA, Varela-Ramirez A, Aguilera RJ, Noveron JC. Novel anticancer alkyl pyridinium derivative exhibits antiproliferative activity via G0/G1 cell cycle arrest and apoptosis activation in triple-negative breast cancer cells. Bioorg Med Chem. 2026 Jun; 137:118638.
    View in: PubMed
    Score: 0.192
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support